14
Dec
Low carbohydrate/ketogenic diet in the optimization of lipoprotein(a) levels: do we have sufficient evidence for any recommendation?
Surma S, Sahebkar A, Banach M; endorsed by the International Lipid Expert Panel (ILEP)
30
Oct
The Baltic – Ukrainian Atherosclerosis Hybride Conference will take place on 10.11.2023. in Tallinn, Estonia
The Baltic – Ukrainian Atherosclerosis Conference will be held in hybrid format in Tallinn on 10.11.2023 at Hilton Tallinn Park Hotel (Fr. R. Kreutzwaldi 23), event will be preceded by Conference pre-session „Familial hypercholesterolemia round-table” on 09.11.23 (same venue). Click baner to see more!
21
Oct
Professor Dimitri P. Mikhailidis has received the first ILEP Honorary Membership Award
We are so happy to announce that Professor Dimitri P. Mikhailidis from the UCL has received the first ILEP Honorary Membership Award. Thank you to all of you for the unanimous support of this award to Professor Mikhailidis. And it is not only related to the fact that prof. Mikhailidis was a co-founder of the […]
06
Oct
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis
In our next meta-analysis (the largest in the world) we showed a significant inverse association between daily step count and all-cause mortality and CV mortality with more the better over the cut-off point of 3867 steps/day for all-cause mortality and only 2337 steps for CV mortality. This confirms that we can start even with the […]
06
Oct
Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data
Within the group of the recognized Polish experts, based on the data from the PL-ACS Registry, for the first time in the world we confirmed that the upfront combination lipid-lowering therapy is superior to statin monotherapy for all-cause mortality in patients with ACS. These results suggest that in high-risk patients, such an approach, rather than […]
06
Oct
Association between electronic nicotine delivery systems use and risk of stroke: a meta-analysis of 1,024,401 participants
Within LBPMC Group we also evaluated the relationship between electronic nicotine delivery systems (ENDS) use and the risk of stroke when compared to non-smokers. The results were presented at the ESC Congress in Amsterdam and published simultaneously in the Archives of Medical Science. https://www.archivesofmedicalscience.com/Association-between-electronic-nicotine-delivery-systems-use-and-risk-of-stroke-a,171473,0,2.html
06
Oct
Low carbohydrate/ketogenic diet in the optimization of lipoprotein(a) levels: do we have sufficient evidence for any recommendation?
Please see the most recent ILEP expert opinion paper, just published in the European Heart Journal, on the role of low carbohydrate diet/ketogenic diet on the concentration and management of evaluated lipoprotein(a) level. – https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehad635/7285571?login=false
09
Jun
The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper.
Bielecka-Dabrowa A, Banach M, Wittczak A, Cicero AFG, Kallel A, Kubilius R, Mikhailidis DP, Sahebkar A, Pantea Stoian A, Vinereanu D, Penson PE, von Haehling S.
07
Mar
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Banach M, Penson PE, Farnier M, Fras Z, Latkovskis G, Laufs U, Paneni F, Parini P, Pirro M, Reiner Ž, Vrablik M, Escobar C.
14
Feb
Individualized therapy in statin intolerance: the key to success
Banach M, Cannon CP, Paneni F, Penson PE; endorsed by the International Lipid Expert Panel (ILEP).